# A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV

> **NCT07053384** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **ViiV Healthcare** · enrollment: 107 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** VH3810109
- **DRUG:** Fostemsavir (FTR)
- **DRUG:** SOC INSTI-based ART

## Key facts

- **NCT ID:** NCT07053384
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-10
- **Primary completion:** 2027-01-22
- **Final completion:** 2028-09-06
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07053384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07053384, "A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07053384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*